Benign Tumors
Oral Schwannoma
aka Neurilemmoma
Benign encapsulated tumour of Schwann cells arising from peripheral nerve sheath; solitary, slow-growing and eccentric to the parent nerve.
Cell
Schwann cell
Marker
S-100+
Rx
Excision
§ overviewOverview
Benign, encapsulated peripheral nerve sheath tumour composed exclusively of well-differentiated Schwann cells.
§ icdICD Classification
D36.1
§ epidemiologyEpidemiology
Tongue is the most common oral site; 25–55% of head-and-neck schwannomas are in the oral cavity; adults 20–50 y.
§ clinicalClinical Features
- 01Slow-growing, painless, firm, submucosal nodule
- 02Usually solitary
- 03May cause paraesthesia if involving lingual/IAN
§ differentialDifferential Diagnosis
- 01Neurofibroma
- 02Fibroma
- 03Lipoma
- 04Salivary gland tumour
§ histopathHistopathology
- 01Encapsulated tumour with Antoni A (compact spindle cells, Verocay bodies) and Antoni B (loose myxoid) areas
- 02Verocay body: nuclear palisading around anuclear zones
§ investigationsInvestigations
- 01MRI: 'target sign' (central low, peripheral high T2)
- 02Fine-needle aspiration unreliable
§ ihcIHC / Special Stains
- 01Strong diffuse S-100 positivity
§ treatmentTreatment
- 01Complete surgical excision with preservation of parent nerve fascicles
- 02Malignant transformation extremely rare
§ complicationsComplications
- 01Nerve injury if excision incomplete
- 02Rare recurrence
§ prognosisPrognosis
Excellent; malignant peripheral nerve sheath tumour only in NF1 setting.
§ examKey Examination Points
- 01Solitary tongue nodule → biopsy
- 02MRI target sign
§ revisionQuick Revision Summary
- 01Antoni A/B · Verocay bodies · S-100+ · excision curative
§ vivaBDS Viva Questions
- 01Antoni A vs B?
- 02Schwannoma vs neurofibroma?
- 03Malignant risk?
§ mcqsMCQs — Assessment (3)
Question 1
Most common oral site:
Question 2
Verocay bodies are found in:
Question 3
IHC marker:
References
- Neville BW. Oral & Maxillofacial Pathology, 4e
Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.